Elizabeth DeGrush to Disease Progression
This is a "connection" page, showing publications Elizabeth DeGrush has written about Disease Progression.
Connection Strength
0.397
-
Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, DeGrush E. The impact of AD drug treatments on event-related potentials as markers of disease conversion. Curr Alzheimer Res. 2013 Sep; 10(7):732-41.
Score: 0.319
-
Chapman RM, McCrary JW, Gardner MN, Sandoval TC, Guillily MD, Reilly LA, DeGrush E. Brain ERP components predict which individuals progress to Alzheimer's disease and which do not. Neurobiol Aging. 2011 Oct; 32(10):1742-55.
Score: 0.062
-
Chapman RM, Mapstone M, McCrary JW, Gardner MN, Porsteinsson A, Sandoval TC, Guillily MD, Degrush E, Reilly LA. Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol. 2011 Feb; 33(2):187-99.
Score: 0.016